Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

1-(5-tert-butyl-2-aryl-pyrazol-3-yl)-3-[2-fluoro-4-[(3-oxo-4H-pyrido [2, 3-B]pyrazin- 8-yl)oxy]phenyl]urea derivatives as RAF inhibitors for the treatment of cancer

US Patent 10167282 · Granted Jan 1, 2019

Assignee

Inventors

View full patent text on Google Patents →